www.worldglaucoma.org
facebook
Конгресс
icglaucoma.org
Основные мероприятия ассоциации офтальмологов
Торика
Ассоциации
icgs2018
Конгресс 2014
santen
конгресс 2018
eye5
Флаги
Шахматы
glaucoma_net_ru
askin_heid
профессор
ВК
Beaver
camopht
medlab
nidek
Первая пятница декабря
bannerparasol
oftalmolog_club
varthamana2
YouTube
Mobile
АйНьюс.РФ
appstore
Главная / Новости

Новости


2 3 4 5 6 7 8 9 10 11


02 апреля 2017 - Новый конкурс на нашем сайте “Три секрета офтальмологии”
Как всегда, подарки гарантируем!

01 апреля 2017 - Update on the Medical Treatment of Primary Open-Angle Glaucoma
Abstract Glaucoma comprises a group of progressive, neurodegenerative disorders characterized by retinal ganglion cell death and nerve fiber layer atrophy. Several randomized controlled trials have consistently demonstrated the efficacy of intraocular pressure lowering to slow or halt the measurable progression of the disease. Medical therapy, in places where it is easily accessible, is often the primary method to lower intraocular pressure. We review the medical options currently available and possible future options currently in development. The 5 contemporary classes of topical agents in use include prostaglandin analogs, beta blockers, carbonic anhydrase inhibitors, alpha agonists, and cholinergics. In addition, several fixed combination agents are commercially available. Agents from each of these classes have unique mechanisms of action, adverse effects, and other characteristics that impact how they are used in clinical practice. Despite the plethora of medical options available, there are limitations to topical ophthalmic therapy such as the high rate of noncompliance and local and systemic adverse effects. Alternate and sustained drug delivery models, such as injectable agents and punctal plug delivery systems, may in the future alleviate some such concerns and lead to increased efficacy of treatment while minimizing adverse effects.

30 марта 2017 - Efficacy With the iStent!
Как только появляется новый девайс/технология, на нее возлагают большие надежды. Но только время покажет, что было лучше: проверенная трабекулэктомия или Istent???

29 марта 2017 - Статья: "Клиническое применение MultiColor"
Информация компании Аскин и Ко о новых возможностях MultiColor SPECTRALIS

28 марта 2017 - Point/Counterpoint: Has a Replacement for Trabeculectomy Finally Arrived?
A new surgical device will substantially reduce the need for this procedure.

21 марта 2017 - Three-month outcome of intravitreal ziv-aflibercept in eyes with diabetic macular oedema
Abstract Purpose We report the 3-month efficacy of monthly intravitreal ziv-aflibercept in patients with diabetic macular oedema (DME).

20 марта 2017 - New Handout “Retinal Layers”: All at a glance!
На сайте компании Гейдельберг Инжиниринг появились интересные новости. Напоминаю, что нужно регистрация

16 марта 2017 - Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up
Purpose: To evaluate the long-term intraocular pressure (IOP)-lowering effect and safety parameters following treatment with two trabecular micro-bypass stents and topical prostaglandin in phakic eyes with open-angle glaucoma (OAG) not controlled on two preoperative medications.

15 марта 2017 - Кажется это уже было?
В свое время ТИ Ерошевский хорошо об этом сказал в начале 70-х. Вот новые данные иностранных коллег Visual function may improve after trabeculectomy in some adults with moderately advanced glaucoma

09 марта 2017 - Head-down Posture in Glaucoma Suspects Induces Changes in IOP, Systemic Pressure, and PERG That Predict Future Loss of Optic Nerve Tissue
Abstract Purpose: To obtain pilot data on posture-induced changes of intraocular pressure (IOP), systemic pressure, and pattern electroretinogram (PERG) predictive of future optic nerve tissue loss glaucoma suspects (GSs). Methods: Mean peripapillary retinal fiber layer thickness (RNFLT) was measured with optical coherence tomography 2 times/year in 28 GS aged 58+/-8.9 years over 5.0+/-0.73 years. All patients had a baseline PERG, IOP, and brachial blood pressure measurements in the seated and -10 degrees head-down-body-tilt (HDT) position. Outcome measures were seated/HDT PERG amplitude and phase, IOP, mean arterial blood pressure, and estimated ocular perfusion pressure. An additional group of 11 similarly aged controls aged 56.9+/-13 years was tested for comparison. Results: Although all GS had initial RNFLT in the normal range, 9/28 of them developed significant (P<0.05) loss of mean RNFLT [thinners (T)] over the follow-up period as opposed to 19/28 who did not [nonthinners (NT)]. Significant (P<0.05) differences between similarly aged controls, NT, and T were found in PERG amplitude, PERG phase, mean arterial blood pressure, IOP, and ocular perfusion pressure. A nominal logistic regression using baseline PERG and hemodynamic variables was able to distinguish T from NT with an area under receiving operator characteristic of 0.89 (SE, 0.07). Conclusions: Baseline PERG, IOP, and systemic blood pressure, together with their changes upon HDT, may have predictive value for future loss of optic nerve tissue in GS. This study supports the rationale for a full-scale clinical trial to identify patients at high risk of development of glaucoma. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.

26 февраля 2017 - Educational slides from the EGS Guidelines
Внимание! Нужна регистрация! Но это того стоит!

24 февраля 2017 - Efficacy With the iStent
Inder Paul Singh, MD, says the iStent (Glaukos) helps physicians reduce medication burden. He provides details on outcomes and discusses why safety makes this device advantageous for surgeons. Dr. Singh also explains how the iStent has improved the overall efficiency of his cataract surgery cases

19 февраля 2017 - The Use of Microperimetry to Detect Functional Progression in Non-Neovascular Age-Related Macular Degeneration: A Systematic Review
We reviewed the current literature on the ability of micro-perimetry to detect non-neovascular age-related macular degeneration (AMD) disease progression. The index test was retinal sensitivity mea-surement assessed by microperimetry and comparators were other func-tional measures (best-corrected and low-luminance visual acuities, and fixation stability) and structural parameters [retinal thickness, choroidal thickness, and area of geographic atrophy (GA) determined by color fun-dus photographs, short-wave or near-infrared fundus autofluorescence].

17 февраля 2017 - Glaucoma: Novel Mechanisms and Treatments that Target the Elusive IOP
Overview Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma medications achieve this almost exclusively through reduction of intraocular pressure (IOP). Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still experience vision loss. Intraocular pressure is the only known modifiable risk factor for patients with glaucoma, so improvements in patient outcomes rely on tight IOP control and patient adherence to therapy. In this educational activity, leading clinicians review established and new therapeutic agents for patients with glaucoma, including the recent clinical evidence for their safety and efficacy. In addition, discussion will comprise the recent evidence concerning the effects of low perfusion pressure on glaucoma development and progression

15 февраля 2017 - Х Российская глаукомная школа, Санкт-Петербург
Полная программа Школы

11 февраля 2017 - Bilateral uveitis after phakic intraocular lens implantation and management with adalimumab
A 25-year-old woman with myopia who had an AC pIOL implantation in the left eye and posterior chamber pIOL implantation in the right eye developed bilateral granulomatous panuveitis 2 months after the second surgery. Physical examination showed bilateral Koeppe and Busacca nodules. Fluorescein angiography showed diffuse vascular and retinal pigment epithelial leakage in both eyes. With assessment of sympathetic ophthalmia, treatment with a high-dose systemic steroid was started. Oral cyclosporine and azathioprine were later added.

08 февраля 2017 - К вопросу о начислении баллов!
Для начисления зачетных единиц, полученных после прохождения обучения в рамках учебного мероприятия (конференция, мастер-класс, заседание профессионального общества), Вам необходимо указать индивидуальный код подтверждения на сайте Координационного совета по развитию непрерывного медицинского и фармацевтического образования Министерства здравоохранения РФ: http://www.sovetnmo.ru.

05 февраля 2017 - Как врачу отказаться от лечения пациента?
1. Лечащий врач по согласованию с руководителем медорганизации может отказаться лечить пациента, если отказ не угрожает жизни больного 2. Решение об отказе нужно передать пациенту либо отправить заказным письмом с уведомлением 3. Если все врачи отказались от наблюдения пациента по предусмотренной законом процедуре, руководитель может предложить гражданину обратиться в иную медорганизацию

03 февраля 2017 - Министерство разработало краткие рекомендации для авторов по подготовке и оформлению научных статей в журналах, индексируемых в международных наукометрических базах данных
Рекомендации детально объясняют публикационный процесс, процедуры рецензирования и опубликования, а также общепринятые требования к структуре научной статьи. Данная информация нацелена на помощь научным работникам и повышение их публикационной активности.

02 февраля 2017 - Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
Purpose: The aim was to evaluate the safety of bilateral same-day injections with intravitreal antiangiogenic drugs for macular diseases. Methods: Cross-sectional retrospective review of unilateral and bilateral same-day antiangiogenic injections was conducted between January 2011 and March 2016 in the Unit of Macula, University and Polytechnic Hospital La Fe (Valencia, Spain). A total of 8,172 injections were administered, among which 6,560 were unilateral and 1,612 were bilateral injections. Patients were included in the study regardless of the diagnosis. Ranibizumab and aflibercept were the antiangiogenic drugs used. The presence of endophthalmitis or retinal detachment was evaluated.


2 3 4 5 6 7 8 9 10 11
Голосование
Что "заставляет" Вас заниматься научными исследованиями?